Inhaled Corticosteroids and Pneumonia in Chronic Obstructive Pulmonary Disease

被引：0

作者：

Malo de Molina, Rosa ^{[1
]}

Restrepo, Marcos I. ^{[2
,3
]}

Mortensen, Eric M. ^{[2
,4
]}

Izquierdo, Jose L. ^{[5
]}

Anzueto, Antonio ^{[2
,3
]}

机构：

[1] Hosp Univ Puerta Hierro Majadahonda, Dept Pulm Med, Madrid, Spain

[2] South Texas Vet Hlth Care Syst, VERDICT Res Unit, San Antonio, TX USA

[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Dept Pulm & Crit Care Med, San Antonio, TX USA

[4] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Gen Internal Med, San Antonio, TX USA

[5] Hosp Univ Guadalajara, Dept Pulm Med, Guadalajara, Spain

来源：

CURRENT RESPIRATORY MEDICINE REVIEWS | 2010年 / 6卷 / 03期

关键词：

Chronic obstructive pulmonary disease; pneumonia; inhaled corticosteroids;

D O I：

10.2174/157339810791526229

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Inhaled corticosteroids (ICS) have been recommended for use in patients with chronic obstructive pulmonary disease (COPD) in order to decrease exacerbation rates and improve health related quality of life parameters. Nevertheless, recent studies have reported an increased risk of pneumonia associated with this treatment. However, most studies were not specifically designed to detect pneumonia as a possible secondary effect and for this reason it is difficult to determine whether this risk exists and assess its magnitude. This paper reviews the published studies reporting pneumonia events in COPD patients treated with ICS.

引用

页码：162 / 166

页数：5

共 50 条

[21] Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease
Bonay, M
Bancal, C
Crestani, B
DRUG SAFETY, 2002, 25 (01) : 57 - 71
[22] Inhaled corticosteroids for stable chronic obstructive pulmonary disease (Review)
Yang, I. A.
Fong, K. M.
Sim, E. H. A.
Black, P. N.
Lasserson, T. J.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02):
[23] Inhaled corticosteroids in chronic obstructive pulmonary disease - Is there a clinical benefit?
Man, SFP
Sin, DD
DRUGS, 2005, 65 (05) : 579 - 591
[24] Inhaled corticosteroids for chronic obstructive pulmonary disease - A status report
Niewoehner, Dennis E.
Wilt, Timothy J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (02) : 103 - 104
[25] Inhaled corticosteroids in chronic obstructive pulmonary disease: Some considerations
Baloira Villar, Adolfo
Nunez Fernandez, Marta
Pallares Sanmartin, Abel
ARCHIVOS DE BRONCONEUMOLOGIA, 2016, 52 (04): : 229 - 229
[26] The Excessive Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Izquierdo Alonso, Jose Luis
Rodriguez Glez-Moro, Jose Miguel
ARCHIVOS DE BRONCONEUMOLOGIA, 2012, 48 (06): : 207 - 212
[27] Safety of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1339): : 41 - 42
[28] The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
Park, Ji Won
Hong, Yoonki
Rhee, Chin Kook
Choi, Hye Sook
Kim, Kyungjoo
Ha Yoo, Kwang
Jung, Ki-Suck
Park, Joo Hun
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 733 - 743
[29] Extent of Overuse of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Kardos, Peter
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (02) : 248 - 249
[30] Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease
Matera, Maria Gabriella
Cardaci, Vittorio
Cazzola, Mario
Rogliani, Paola
EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 533 - 541

← 1 2 3 4 5 →